LogoLogo
search
⌘Ctrlk
Digital Twin SafeClinipediaRight to Trial ActAPI DocsWikidFDA
LogoLogo
  • 💊The Decentralized FDA
  • 📘Historical Evidence Supporting Decentralized Efficacy Trials
  • ☠️Problems With the Current Model
    • 🥫No Data on Unpatentable Molecules
    • 💰Clinical Research is Expensive
    • 🥸Trials Often Aren't Representative of Real Patients
    • ❓We Know Next to Nothing
    • ⏱️Deaths Due to US Regulatory "Drug Lag"
    • 🙈Negative Results are Never Published
    • 🎭Conflicts of Interest
    • 🗓️No Long-Term Outcome Data
    • 📃Lack of Incentive to Discover the Full Range of Applications for Off-Patent Treatments
    • 🤒People With Rare Disease are Severely Punished
    • 🔮Pre-Determining Clinical Endpoints Requires Psychic Powers
  • 🎯Benefits of a Decentralized Model
  • 📖References
gitbookPowered by GitBook
block-quoteOn this pagechevron-down
githubEdit

☠️Problems With the Current Model

The current system of clinical research is too slow, expensive, and imprecise.

🥫No Data on Unpatentable Moleculeschevron-right📃Lack of Incentive to Discover the Full Range of Applications for Off-Patent Treatmentschevron-right🗓️No Long-Term Outcome Datachevron-right🎭Conflicts of Interestchevron-right🙈Negative Results are Never Publishedchevron-right🥸Trials Often Aren't Representative of Real Patientschevron-right
PreviousHistorical Evidence Supporting Decentralized Efficacy Trialschevron-leftNextNo Data on Unpatentable Moleculeschevron-right

Last updated 1 year ago

Was this helpful?

Links

  • API Docs
  • Right to Trial Act

Was this helpful?